References
- World Health Organization (WHO) vaccine-preventable diseases: monitoring system 2006. Global summary Available from: http://www.who.int/vaccinesdocuments/GlobalSummary/GlobalSummary.pdf
- Crowcroft NS, Stein C, Duclos P, Birmingham M. How best to estimate the global burden of pertussis?. Lancet Infect Dis 2003; 3:413 - 418
- Tan T, Trindade E, Skowronski D. Epidemiology of pertussis. Pediatr Infect Dis J 2005; 24:10 - 18
- Wendelboe AM, Van Rie A, Salmaso S, Englund JA. Duration of immunity against pertussis after natural infection or vaccination. Pediatr Infect Dis J 2005; 24:58 - 61
- Wearing HJ, Rohani P. Estimating the duration of pertussis immunity using epidemiological signatures. PLoS Pathog 2009; 5:1000647
- Hellenbrand W, Beier D, Jensen E, Littmann M, Meyer C, Oppermann H, et al. The epidemiology of pertussis in Germany: past and present. BMC Infect Dis 2009; 9:22
- Brooks DA, Clover R. Pertussis infection in the United States: role for vaccination of adolescents and adults. J Am Board Fam Med 2006; 19:603 - 611
- Cherry JD. The epidemiology of pertussis: a comparison of the epidemiology of the disease pertussis with the epidemiology of Bordetella pertussis infection. Pediatrics 2005; 115:1422 - 1427
- EUVAC.Net. Pertussis surveillance report 2003–2007 21 December 2009 Available at http://www.euvac.net/graphics/euvac/pdf/pertussis2.pdf.
- Zepp F, Bernatowska E, Guiso N, Heininger U, Mertsola J, Roord J, et al. Consensus on pertussis booster vaccination in Europe (C.O.P.E) 2009 17 March 2010 Abstract presented at ESPID 2009 http://www.kenes.com/espid09/abstracts/pdf/426.pdf
- Davis JP. Clinical and economic effects of pertussis outbreaks. Pediatr Infect Dis J 2005; 24:109 - 116
- Kretsinger K, Broder KR, Cortese MM, Joyce MP, Ortega-Sanchez I, Lee GM, et al. Preventing Tetanus, Diphtheria and Pertussis among ADULTS: Use of Tetanus Toxoid, Reduced Diphtheria Toxoid and Acellular Pertussis Vaccines. MMWR Recommendations and Reports 2006; 55:1 - 33
- Forsyth K, Nagai M, Lepetic A, Trindade E. Pertussis immunization in the global pertussis initiative international region: recommended strategies and implementation considerations. Pediatr Infect Dis J 2005; 24:93 - 97
- Zepp F. Standige Impfkommission am Robert-Koch-Institut (STIKO). [Revaccination against pertussis. Recommendations from STIKO (Standing Vaccination Commission of the Robert Koch Institute)]. Med Monatsschr Pharm 2001; 24:51 - 53
- Robert Koch Institut. [Communication from the Permanent Vaccination Commission at the Robert Koch Institute Recommendations of the Standing Vaccination Commission (STIKO)]. Epidemiologisches Bulletin 2009; 13:279 - 298 Available at: http://edoc.rki.de/documents/rki_ab/reh7ZeuiN43iY/PDF/29sFAiTr0AQ8w.pdf.
- Schaade L, Widders U, Stange G, Höhl N. [Vaccination recommendations of the Standing Committee on Vaccination at the Robert Koch Institute: Legal basis and significance.]. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz 2009; 52:1006 - 1010
- Wilder-Smith A, Boudville I, Earnest A, Heng SL, Bock HL. Knowledge, attitude and practices with regard to adult pertussis vaccine booster in travelers. J Travel Med 2007; 14:145 - 150
- Loulergue P, Moulin F, Vidal-Trecan G, Absi Z, Demontpion C, Menager C, et al. Knowledge, attitudes and vaccination coverage of healthcare workers regarding occupational vaccinations. Vaccine 2009; 27:4240 - 4243